CIK 0001604464
- Non-accelerated filer
- Smaller reporting company
Atara Biotherapeutics, Inc.
Sign in to watch- Ticker
- ATRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460920988
- Phone
- +1 805-623-4211
- Business address
- 1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
- Open-market buys, last 90 days
- $999,994
- in 1 filing
- Open-market sales, last 90 days
- $39,368
- in 1 filing
Net +$960,625. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 3 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-05-15 | Soffer Gad EVP & Chief Strategy Officer | Exercise or conversion · Restricted Stock Units | −4,146 | 11,055 | ||
| 2017-05-10 | Porter Derrell SVP, Head of Global Commercial | Grant or award · Employee Stock Option (Right to Buy) | +130,000 | 130,000 | ||
| 2017-04-26 | Ciechanover Isaac E. Chief Executive Officer | Sale | −3,600 | $17.78 | $64K | 467,778 |
| 2017-04-25 | Ciechanover Isaac E. Chief Executive Officer | Sale | −2,100 | $17.07 | $36K | 472,878 |
| 2017-04-25 | Ciechanover Isaac E. Chief Executive Officer | Sale | −1,500 | $17.70 | $27K | 471,378 |
| 2017-04-17 | Haqq Christopher EVP, R&D & Chief Scientific Of | Sale | −6,000 | $17.28 | $104K | 380,855 |
| 2017-04-11 | Ciechanover Isaac E. Chief Executive Officer | Sale | −4,200 | $16.99 | $71K | 474,978 |
| 2017-04-10 | Ciechanover Isaac E. Chief Executive Officer | Sale | −3,000 | $17.08 | $51K | 479,178 |
| 2017-04-03 | Newell Joe Chief Tech. Operations Officer | Grant or award | +7,500 | 7,500 | ||
| 2017-04-03 | Newell Joe Chief Tech. Operations Officer | Grant or award · Employee Stock Option (Right to Buy) | +90,000 | 90,000 | ||
| 2017-03-28 | Ciechanover Isaac E. Chief Executive Officer | Sale | −3,182 | $18.99 | $60K | 482,596 |
| 2017-03-28 | Ciechanover Isaac E. Chief Executive Officer | Sale | −418 | $19.86 | $8K | 482,178 |
| 2017-03-27 | Ciechanover Isaac E. Chief Executive Officer | Sale | −12,400 | $20.34 | $252K | 485,778 |
| 2017-03-23 | MCGRATH JOHN EVP & Chief Financial Officer | Sale | −6,500 | $21.08 | $137K | 112,827 |
| 2017-03-22 | MCGRATH JOHN EVP & Chief Financial Officer | Sale | −7,500 | $20.27 | $152K | 119,327 |
| 2017-03-17 | Ciechanover Isaac E. Chief Executive Officer | Sale | −2,400 | $18.50 | $44K | 515,778 |
| 2017-03-17 | Ciechanover Isaac E. Chief Executive Officer | Sale | −17,600 | $20.01 | $352K | 498,178 |
| 2017-03-16 | Ciechanover Isaac E. Chief Executive Officer | Sale | −10,800 | $18.54 | $200K | 518,178 |
| 2017-03-15 | Haqq Christopher EVP, R&D & Chief Scientific Of | Sale | −6,000 | $19.60 | $118K | 386,855 |
| 2017-03-10 | Soffer Gad EVP & Chief Strategy Officer | Sale | −2,500 | $20.00 | $50K | 266,527 |
Page 45 of 71 · 1,403 trades